Cogstate Limited (ASX:CGS)
3.080
0.00 (0.00%)
Sep 3, 2026, 11:34 AM AEST
Cogstate Revenue
In the fiscal year ending June 30, 2026, Cogstate had annual revenue of $60.86M USD with 14.64% growth. Cogstate had revenue of $33.94M in the half year ending June 30, 2026, with 45.94% growth.
Revenue
$60.86M
Revenue Growth
+14.64%
P/S Ratio
5.95
Revenue / Employee
$380.40K
Employees
160
Market Cap
523.35M AUD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 60.86M | 7.77M | 14.64% |
| Jun 30, 2025 | 53.09M | 9.66M | 22.25% |
| Jun 30, 2024 | 43.43M | 2.98M | 7.36% |
| Jun 30, 2023 | 40.45M | -4.53M | -10.07% |
| Jun 30, 2022 | 44.98M | 12.28M | 37.57% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Doctor Care Anywhere Group | 75.18M |
| Alcidion Group | 51.64M |
| Mach7 Technologies | 29.70M |
| Oneview Healthcare | 18.40M |
| Pharmx Technologies | 7.62M |
| Vitasora Health | 4.84M |
| Singular Health Group | 2.34M |
| Echo IQ | 1.37M |
Cogstate News
- 14 days ago - Cogstate (ASX:CGS) -- Strong Growth and Market Leadership | Lakehouse Capital Q2 2026 - GuruFocus
- 16 days ago - Cogstate Earnings Call Transcript: H2 2026 - Transcripts
- 16 days ago - Cogstate Annual report: H2 2026 - Filings
- 16 days ago - Cogstate Earnings release: H2 2026 - Filings
- 16 days ago - Cogstate Slides: H2 2026 - Filings
- 2 months ago - Cogstate Transcript: Status update - Transcripts
- 2 months ago - Cogstate Slides: Status update - Filings
- 6 months ago - Cogstate Earnings Call Transcript: H1 2026 - Transcripts